Cargando…
Platforms for Personalized Polytherapeutics Discovery in COVID-19
The COVID-19 pandemic entered its third and most intense to date wave of infections in November 2020. This perspective article describes how combination therapies (polytherapeutics) are a needed focus for helping battle the severity of complications from SARS-CoV-2 infection. It outlines the types o...
Autores principales: | Hopkins, Christopher, Onweni, Chidinma, Zambito, Victoria, Fairweather, DeLisa, McCormick, Kathryn, Ebihara, Hideki, Caulfield, Thomas, Zhang, Yu Shrike, Freeman, W. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979270/ https://www.ncbi.nlm.nih.gov/pubmed/33753053 http://dx.doi.org/10.1016/j.jmb.2021.166945 |
Ejemplares similares
-
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking
por: Onweni, Chidinma L., et al.
Publicado: (2020) -
Polytherapeutic strategies with oncolytic virus–bortezomib and adjuvant NK cells in cancer treatment
por: Aspirin, Angelica P., et al.
Publicado: (2021) -
A randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus
por: Searchfield, Grant D., et al.
Publicado: (2022) -
How I use transcranial Doppler in the ICU
por: Onweni, Chidinma L., et al.
Publicado: (2020) -
Sudden Collapse in the First Trimester: Report of Hyperacute Renal Failure Secondary to Collapsing Glomerulopathy as the Initial Presentation of Lupus
por: Sethi, Pooja, et al.
Publicado: (2017)